Cargando…

Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast

Tumor immune microenvironment plays a crucial role in tumor progression. We performed immune profiling to compare immune-related gene expression between ductal carcinoma in situ (DCIS) and invasive carcinoma of the breast using nCounter PanCancer immune Profiling Panel and found that CXCL10 was the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Milim, Choi, Hye Yeon, Woo, Ji Won, Chung, Yul Ri, Park, So Yeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429587/ https://www.ncbi.nlm.nih.gov/pubmed/34504204 http://dx.doi.org/10.1038/s41598-021-97390-5

Ejemplares similares

Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast
por: Kim, Milim, et al.
Publicado: (2020)

Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers
por: Woo, Ji Won, et al.
Publicado: (2020)

Expression of HLA class I is associated with immune cell infiltration and patient outcome in breast cancer
por: Han, Song-Hee, et al.
Publicado: (2022)

Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer
por: Ahn, Soomin, et al.
Publicado: (2020)

Mammary Carcinoma Arising in Microglandular Adenosis: A Report of Five Cases
por: Kim, Mimi, et al.
Publicado: (2017)

FGFR1 is amplified during the progression of in situ to invasive breast carcinoma
por: Jang, Min Hye, et al.
Publicado: (2012)

Clinical implications of changes in the diversity of c-MYC copy number variation after neoadjuvant chemotherapy in breast cancer
por: Chung, Yul Ri, et al.
Publicado: (2018)

Microinvasive Carcinoma versus Ductal Carcinoma In Situ: A Comparison of Clinicopathological Features and Clinical Outcomes
por: Kim, Milim, et al.
Publicado: (2018)

Invasive Cribriform Carcinoma Arising in Malignant Phyllodes Tumor of Breast: A Case Report
por: Choi, Yoomi, et al.
Publicado: (2012)

Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience
por: Kim, Milim, et al.
Publicado: (2018)

Interobserver Variability of Ki-67 Measurement in Breast Cancer
por: Chung, Yul Ri, et al.
Publicado: (2016)

A comparison of Ki-67 counting methods in luminal Breast Cancer: The Average Method vs. the Hot Spot Method
por: Jang, Min Hye, et al.
Publicado: (2017)

MicroRNA-222 Expression as a Predictive Marker for Tumor Progression in Hormone Receptor-Positive Breast Cancer
por: Han, Song-Hee, et al.
Publicado: (2017)

Negative Conversion of Progesterone Receptor Status after Primary Systemic Therapy Is Associated with Poor Clinical Outcome in Patients with Breast Cancer
por: Ahn, Soomin, et al.
Publicado: (2018)

Benign Intraductal Papilloma without Atypia on Core Needle Biopsy Has a Low Rate of Upgrading to Malignancy after Excision
por: Han, Song-Hee, et al.
Publicado: (2018)

Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value
por: Woo, Ji Won, et al.
Publicado: (2019)

Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance
por: Gwak, Jae Moon, et al.
Publicado: (2017)

Invasive Micropapillary Carcinoma in Axillary Ectopic Breast and Synchronous Ductal Carcinoma In Situ in the Contralateral Breast
por: Oh, Seung Won, et al.
Publicado: (2017)

IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression
por: Kim, Hoe Suk, et al.
Publicado: (2018)

Carcinoma in situ to invasive breast cancer
por: van Deurzen, Carolien H.M., et al.
Publicado: (2015)

Progression of ductal carcinoma in situ to invasive breast cancer: comparative genomic sequencing
por: Doebar, S. C., et al.
Publicado: (2018)

Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer
por: Chung, Yul Ri, et al.
Publicado: (2021)

The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression
por: Yin, Xiaowan, et al.
Publicado: (2019)

Diversity index as a novel prognostic factor in breast cancer
por: Chung, Yul Ri, et al.
Publicado: (2017)

Ductal carcinoma in situ: a risk prediction model for the underestimation of invasive breast cancer
por: Park, Ko Woon, et al.
Publicado: (2022)

Efficacy of breast MRI for surgical decision in patients with breast cancer: ductal carcinoma in situ versus invasive ductal carcinoma
por: Lee, Jeeyeon, et al.
Publicado: (2020)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

DNA methylation and gene expression patterns in breast cancer progression from in situ carcinoma to invasive carcinoma
por: Fleischer, Thomas, et al.
Publicado: (2013)

Identification of aberrant gene expression during breast ductal carcinoma in situ progression to invasive ductal carcinoma
por: Song, Guiqin, et al.
Publicado: (2019)

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
por: Kim, Shinn Young, et al.
Publicado: (2015)

Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis
por: Rabquer, Bradley J, et al.
Publicado: (2011)

Genetic alterations in ductal carcinoma in situ and invasive carcinoma of the breast
por: Robanus-Maandag, E, et al.
Publicado: (2000)

The role of stromal immune microenvironment in the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer
por: Niwińska, Anna, et al.
Publicado: (2021)

Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast
por: Millis, R R, et al.
Publicado: (2004)

CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients
por: Wang, Cuini, et al.
Publicado: (2016)

An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast
por: Kim, Sanghwa, et al.
Publicado: (2019)

Expression of Leptin, Leptin Receptor, Adiponectin, and Adiponectin Receptor in Ductal Carcinoma In Situ and Invasive Breast Cancer
por: Jeong, Young-Ju, et al.
Publicado: (2011)

Association of circulating CXCL10 and CXCL11 with systemic sclerosis
por: Crescioli, Clara, et al.
Publicado: (2018)

Overproduction of CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 in β-thalassemia major or patients
por: Najmaddini, Hamid, et al.
Publicado: (2014)

CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B
por: Yu, Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rju38ud3bhi5fu4h0te527ntt8